Zafranskaya, Marina <br/><br/>
Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.  [electronic resource] 

 -  Immunology  May 2007 
 - 29-39 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0019-2805 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2567.2006.02518.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cell Proliferation<br/>Cells, Cultured<br/>Cytokines--biosynthesis<br/>Disease Progression<br/>Flow Cytometry<br/>Humans<br/>Immunologic Memory<br/>Immunophenotyping<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon-beta--therapeutic use<br/>Leukocyte Common Antigens--blood<br/>Lymphocyte Activation--immunology<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--immunology<br/>Myelin Proteins<br/>Myelin-Associated Glycoprotein--immunology<br/>Myelin-Oligodendrocyte Glycoprotein<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 1<br/>T-Lymphocyte Subsets--immunology